DNA-PK
DNA-PK is a serine/threonine kinase and acts a molecular sensor for DNA damage. It is involved in NHEJ (non-homologous end joining) for DSB (DNA double strand break) repair and V(D)J recombination.
Products for DNA-PK
- Cat.No. Product Name Information
-
GC64818
AMA-37
AMA-37, an Arylmorpholine analog, is ATP-competitive DNA-PK inhibitor, with IC50 values of 0.27 μM (DNA-PK), 32 μM (p110α), 3.7 μM (p110β), and 22 μM (p110γ), respectively.
-
GC64938
AZD-7648
AZD-7648 is a potent, orally active, selective DNA-PK inhibitor with an IC50 of 0.6 nM. AZD-7648 induces apoptosis and shows antitumor activity.
-
GC16654
CC-115
mTOR/DNA-PK inhibitor
-
GC34121
CC-115 hydrochloride
CC-115 hydrochloride is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM and 21 nM, respectively. CC-115 blocks both mTORC1 and mTORC2 signaling.
-
GC10812
Compound 401
DNA-PK and mTOR inhibitor
-
GC74026
DNA-PK-IN-12
DNA-PK-IN-12 (compound 31t) is an oral active DNA-PK inhibitor with the IC50 of 0.1 nM.
-
GC10196
ETP-46464
ATM Inhibitor III, ATR Inhibitor III
ATR inhibitor,potent and selective -
GC14346
KU-0060648
Dual DNA-PK/PI3-K inhibitor, ATP-competitive
-
GC19227
LTURM34
LTURM34 is a specific DNA-PK inhibitor with an IC50 of 0.034 uM.
-
GC50009
LY 294002 hydrochloride
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
-
GC14371
LY3023414
LY3023414
LY3023414 (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. LY3023414 potently inhibits mTORC1/2 at low nanomolar concentrations. -
GC73792
Lys(CO-C3-p-I-Ph)-O-tBu
Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules.
-
GC73791
Lys(CO-C3-p-I-Ph)-OMe
Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium).
-
GC12332
NU 7026
DNAPK Inhibitor II, LY293646
DNPK inhibitor,ATP-competitive and potent -
GC11251
NU7441 (KU-57788)
KU 57788; NU-7441;KU57788;NU7441;NU 7441
NU7441 (KU-57788) is a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 of 13nM. NU7441 also inhibits phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) with IC50 of 5.0 and 1.7μM, respectively. -
GC11165
PI-103
Class I PI3K, mTOR and DNA-PK inhibitor
-
GC16904
PIK-75
PIK-75 is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM). PIK-75 induces apoptosis.
-
GC17199
PIK-90
PIK85
PI3K inhibitor,potent selective -
GC19328
SF2523
SF2523 is a highly selective and potent inhibitor of PI3K with IC50s of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM for PI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively.
-
GC65249
STL127705
STL127705 (Compound L) is a potent Ku 70/80 heterodimer protein inhibitor with an IC50 of 3.5 μM. STL127705 interferes the binding of Ku70/80 to DNA and by inhibits the activation of the DNA-PKCS kinase. STL127705 shows antiproliferative and anticancer activity. STL127705 induces apoptosis.
-
GC13858
Torin 2
MTOR inhibitor,highly potent and selective
-
GC33325
VX-984 (M9831)
M9831
VX-984 (M9831) (M9831) is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 (M9831) efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 (M9831) can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research. -
GC19390
YU238259
YU238259 is an inhibitor of homology-dependent DNA repair (HDR), used for cancer research.